Live WebinarA new SPLIT CREST technique
23 Oct 2020, 11:00 PM Shanghai
Prof. Tomaso Vercellotti
Live WebinarInflammation and type 2 diabetes: pathogenesis and current treatment protocols
Marc Y. Donath MD
As a possible causal therapy, inflammatory mediators may help. This is supported by clinical studies showing that IL-1 antagonism decreases glycated hemoglobin. Furthermore, IL-1 antagonism prevents heart failure and cardiovascular diseases, the major complications of diabetes and may also prevent microvascular complications.
Lecture will cover the pathogenesis of type 2 diabetes, overview of current treatment protocols and potential of future anti-inflammatory treatment, including impact on periodontitis.